Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05687994

Speech Entrainment Treatment for People With Aphasia

Conditions: Aphasia, Acquired

Sex: All
Ages: 18 Years – 80 Years
Phase: NA
Enrollment: 40
Sponsor: Albert Einstein Healthcare Network

Location: United States

Summary

The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.

Eligibility Criteria

Inclusion Criteria:Between 18-80 years at the time of enrollmentEnglish as native languagegreater than six months post onsetDiagnosis of aphasia based on Western Aphasia Battery - Revised (WAB-R)Score of 7 or less on the Fluency subsection of the WAB-RDemonstrate having the willingness and stamina to participate in the multiple-session protocol, either by traveling to the MRRI testing site or being tested at homeExclusion Criteria:History of learning disabilitiesHistory of other comorbid neurological impairments

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05687994). StuddyBuddy aggregates publicly available trial information.